Löddeköpinge, Sweden

Björn Ullbrand

This inventor holds 2 USPTO granted patents. Top assignee: Astrazeneca Ab. Active years: 2003.


% Patents Active = 50.0

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 46(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Björn Ullbrand: Innovator in Inhalation Devices

Introduction

Björn Ullbrand is a notable inventor based in Löddeköpinge, Sweden. He has made significant contributions to the field of inhalation devices, focusing on the administration of powdered medicaments. With a total of 2 patents to his name, Ullbrand's work is recognized for its innovative approach to improving patient care.

Latest Patents

Ullbrand's latest patents include an inhalation device designed for administering powdered medicaments. This device features a suction tube that allows the medicament to be drawn in by the user during inhalation. The design includes a blister pack and a housing that supports the blister pack, with the suction tube being removable for user convenience. Additionally, a resilient member is incorporated to ensure the suction tube is easily graspable when the device is ready for use. Another patent involves a blister pack assembly for an inhaler, which comprises a suction tube and a blister pack unit containing multiple doses of the medicament.

Career Highlights

Björn Ullbrand is associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to focus on developing innovative solutions for inhalation therapies, contributing to advancements in the medical field.

Collaborations

Ullbrand has collaborated with notable colleagues such as Alfred Von Schuckmann and Anders Selmer. These partnerships have fostered a creative environment that encourages the development of cutting-edge medical devices.

Conclusion

Björn Ullbrand's contributions to inhalation device technology highlight his commitment to improving healthcare solutions. His innovative patents and collaborations reflect a dedication to enhancing patient experiences through effective medicament delivery systems.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…